Evidence map›Paper›PMID 27558013›Full record

ArticleHLA2016

HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands.

E Ashouri, P J Norman, L A Guethlein, A S Han, N Nemat-Gorgani, S J Norberg, A Ghaderi, P Parham

Abstract read
In one paragraph

Article in HLA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Sequences of 95 humanGenome research · 2017
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

E AshouriDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
P J NormanDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
L A GuethleinDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
A S HanDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
N Nemat-GorganiDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
S J NorbergIllumina Inc, San Diego, CA, USA.
A GhaderiShiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
P ParhamDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA.
Stanford University · USIllumina (United States) · USShiraz University of Medical Sciences · IR

Funding

GENETICS TRAINING PROGRAM FOR PHD CANDIDATEST32GM007790 · NIGMS · STANFORD UNIVERSITY · PI BRUNET, ANNE, KINGSLEY, DAVID M · 1985 to 2020
$12.8M
STRUCTURAL BIOLOGY OF HLA-A,B ANTIGENSR01AI017892 · NIAID · STANFORD UNIVERSITY · PI PARHAM, PETER R · 1985 to 2019
$6.1M
NIAID NIH HHS R01 AI017892NIGMS NIH HHS T32 GM007790
6 · The paper itself

Abstract

HLA-A, -B and -C alleles of 285 individuals, representing three Iranian Lur populations and one Iranian Kurd population were sequenced completely, yielding human leukocyte antigen (HLA) class I genotypes at high resolution and filling four fields of the official HLA nomenclature. Each population has 87-99 alleles, evenly distributed between the three HLA class I genes, 145 alleles being identified in total. These alleles were already known, named and deposited in the HLA database. The alleles form 316 different HLA A-B-C haplotypes, with each population having between 80 and 112 haplotypes. The four Iranian populations form a related group that is distinguished from other populations, including other Iranians. All four KIR ligands - the A3/11, Bw4, C1 and C2 epitopes - are well represented, particularly Bw4, which is carried by three high-frequency allotypes: HLA-A*24:02, HLA-A*32:01 and HLA-B*51:01. In the Lur and Kurd populations, between 82% and 94% of individuals have the Bw4 epitope, the ligand for KIR3DL1. HLA-B*51:01 is likely of Neandertal origin and associated with Behcet's disease, also known as the Silk Road disease. The Lordegan Lur have the highest frequency of HLA-B*51:01 in the world. This allele is present on 46 Lur and Kurd haplotypes. Present at lower frequency is HLA-B*51:08, which is also associated with Behcet's disease. In the four Iranian populations, 31 haplotypes encode both Bw4(+) HLA-A and Bw4(+) HLA-B, a dual combination of Bw4 epitopes that is relatively rare in other populations, worldwide. This study both demonstrates and emphasizes the value of studying HLA class I polymorphism at highest resolution in anthropologically well-defined populations.

Indexed as

EthnicityPolymorphism, GeneticAllelesDatabases, GeneticEpitopesGene ExpressionGene FrequencyGenotypeHaplotypesHigh-Throughput Nucleotide SequencingHLA-A AntigensHLA-B AntigensHLA-C AntigensHumansIranLigandsEpitopesHLA-A AntigensHLA-B AntigensHLA-C AntigensLigandsReceptors, KIRBw4 epitopehigh-throughput sequencingHLA-B*51:01HLA class I polymorphismLur and Kurd populations

Identifiers

PMID27558013
PMCPMC5063635
OpenAlexW2518412580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.